vs
Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Affinity Bancshares, Inc. (AFBI). Click either name above to swap in a different company.
Affinity Bancshares, Inc. is the larger business by last-quarter revenue ($8.6M vs $8.1M, roughly 1.1× Arcellx, Inc.). Affinity Bancshares, Inc. runs the higher net margin — 24.9% vs -766.0%, a 790.9% gap on every dollar of revenue. On growth, Affinity Bancshares, Inc. posted the faster year-over-year revenue change (12.8% vs -79.3%). Affinity Bancshares, Inc. produced more free cash flow last quarter ($11.2M vs $-63.9M). Over the past eight quarters, Affinity Bancshares, Inc.'s revenue compounded faster (8.1% CAGR vs -24.6%).
Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.
ACLX vs AFBI — Head-to-Head
Income Statement — Q1 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $8.1M | $8.6M |
| Net Profit | $-62.3M | $2.1M |
| Gross Margin | — | — |
| Operating Margin | -847.6% | 35.9% |
| Net Margin | -766.0% | 24.9% |
| Revenue YoY | -79.3% | 12.8% |
| Net Profit YoY | -765.1% | 58.5% |
| EPS (diluted) | $-1.13 | $0.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $8.6M | ||
| Q3 25 | — | $8.4M | ||
| Q2 25 | — | $8.3M | ||
| Q1 25 | $8.1M | $7.8M | ||
| Q4 24 | $15.3M | $7.6M | ||
| Q3 24 | $26.0M | $8.0M | ||
| Q2 24 | $27.4M | $8.3M | ||
| Q1 24 | $39.3M | $7.3M |
| Q4 25 | — | $2.1M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | $-62.3M | $1.8M | ||
| Q4 24 | $-47.1M | $1.3M | ||
| Q3 24 | $-25.9M | $1.7M | ||
| Q2 24 | $-27.2M | $1.0M | ||
| Q1 24 | $-7.2M | $1.3M |
| Q4 25 | — | 35.9% | ||
| Q3 25 | — | 34.9% | ||
| Q2 25 | — | 34.1% | ||
| Q1 25 | -847.6% | 30.8% | ||
| Q4 24 | -348.2% | 21.1% | ||
| Q3 24 | -129.1% | 28.5% | ||
| Q2 24 | -127.8% | 16.2% | ||
| Q1 24 | -40.3% | 24.0% |
| Q4 25 | — | 24.9% | ||
| Q3 25 | — | 26.5% | ||
| Q2 25 | — | 25.9% | ||
| Q1 25 | -766.0% | 23.4% | ||
| Q4 24 | -308.4% | 17.7% | ||
| Q3 24 | -99.4% | 21.7% | ||
| Q2 24 | -99.3% | 12.5% | ||
| Q1 24 | -18.3% | 18.2% |
| Q4 25 | — | $0.34 | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | — | $0.33 | ||
| Q1 25 | $-1.13 | $0.28 | ||
| Q4 24 | $-0.87 | $0.21 | ||
| Q3 24 | $-0.48 | $0.26 | ||
| Q2 24 | $-0.51 | $0.16 | ||
| Q1 24 | $-0.14 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $543.3M | $53.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $416.9M | $127.0M |
| Total Assets | $648.1M | $881.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $53.9M | ||
| Q3 25 | — | $84.8M | ||
| Q2 25 | — | $89.7M | ||
| Q1 25 | $543.3M | $74.7M | ||
| Q4 24 | $587.4M | $41.4M | ||
| Q3 24 | $574.3M | $52.3M | ||
| Q2 24 | $516.7M | $50.4M | ||
| Q1 24 | $573.9M | $61.4M |
| Q4 25 | — | $127.0M | ||
| Q3 25 | — | $125.4M | ||
| Q2 25 | — | $124.1M | ||
| Q1 25 | $416.9M | $122.3M | ||
| Q4 24 | $454.8M | $129.1M | ||
| Q3 24 | $483.0M | $128.4M | ||
| Q2 24 | $487.2M | $125.1M | ||
| Q1 24 | $496.6M | $123.3M |
| Q4 25 | — | $881.7M | ||
| Q3 25 | — | $925.2M | ||
| Q2 25 | — | $933.8M | ||
| Q1 25 | $648.1M | $912.5M | ||
| Q4 24 | $711.3M | $866.8M | ||
| Q3 24 | $764.9M | $878.6M | ||
| Q2 24 | $734.3M | $873.6M | ||
| Q1 24 | $779.7M | $869.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.1M | $11.6M |
| Free Cash FlowOCF − Capex | $-63.9M | $11.2M |
| FCF MarginFCF / Revenue | -786.4% | 130.9% |
| Capex IntensityCapex / Revenue | 9.6% | 4.9% |
| Cash ConversionOCF / Net Profit | — | 5.46× |
| TTM Free Cash FlowTrailing 4 quarters | $-122.5M | $20.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $3.7M | ||
| Q2 25 | — | $3.8M | ||
| Q1 25 | $-63.1M | $1.9M | ||
| Q4 24 | $-46.0M | $6.8M | ||
| Q3 24 | $30.7M | $4.1M | ||
| Q2 24 | $-36.2M | $619.0K | ||
| Q1 24 | $-31.9M | $1.2M |
| Q4 25 | — | $11.2M | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | $-63.9M | $1.8M | ||
| Q4 24 | $-47.5M | $6.4M | ||
| Q3 24 | $28.4M | $4.0M | ||
| Q2 24 | $-39.5M | $489.0K | ||
| Q1 24 | $-38.3M | $1.1M |
| Q4 25 | — | 130.9% | ||
| Q3 25 | — | 43.3% | ||
| Q2 25 | — | 44.0% | ||
| Q1 25 | -786.4% | 22.7% | ||
| Q4 24 | -311.3% | 83.9% | ||
| Q3 24 | 109.2% | 49.5% | ||
| Q2 24 | -144.1% | 5.9% | ||
| Q1 24 | -97.7% | 14.8% |
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.4% | ||
| Q1 25 | 9.6% | 1.9% | ||
| Q4 24 | 9.8% | 5.6% | ||
| Q3 24 | 8.8% | 1.7% | ||
| Q2 24 | 11.7% | 1.6% | ||
| Q1 24 | 16.4% | 1.8% |
| Q4 25 | — | 5.46× | ||
| Q3 25 | — | 1.66× | ||
| Q2 25 | — | 1.75× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | 5.05× | ||
| Q3 24 | — | 2.36× | ||
| Q2 24 | — | 0.60× | ||
| Q1 24 | — | 0.91× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
